Japan Inactivated Vaccine Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Inactivated Vaccine market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Inactivated Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Inactivated Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Pfizer (U.S.)

    • GlaxoSmithKline (U.K.)

    • Emergent BioSolutions (U.S.)

    • Serum Institute of India Pvt (India)

    • Johnson & Johnson (U.S.)

    • MedImmune (U.S.)

    • Merck & Co (U.S.)

    • Astellas Pharma (Japan)

    • Pfizer (US)

    • Sanofi Pasteur (France)

    By Type:

    • Pediatrics

    • Adults

    By End-User:

    • Hospital

    • Medical Center

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Inactivated Vaccine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Inactivated Vaccine Market Size and Growth Rate of Pediatrics from 2014 to 2026

      • 1.3.2 Japan Inactivated Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Inactivated Vaccine Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.2 Japan Inactivated Vaccine Market Size and Growth Rate of Medical Center from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Inactivated Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Inactivated Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Pediatrics

      • 3.4.2 Market Size and Growth Rate of Adults

    4 Segmentation of Inactivated Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Inactivated Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Inactivated Vaccine in Hospital

      • 4.4.2 Market Size and Growth Rate of Inactivated Vaccine in Medical Center

    5 Market Analysis by Regions

    • 5.1 Japan Inactivated Vaccine Production Analysis by Regions

    • 5.2 Japan Inactivated Vaccine Consumption Analysis by Regions

    6 Hokkaido Inactivated Vaccine Landscape Analysis

    • 6.1 Hokkaido Inactivated Vaccine Landscape Analysis by Major Types

    • 6.2 Hokkaido Inactivated Vaccine Landscape Analysis by Major End-Users

    7 Tohoku Inactivated Vaccine Landscape Analysis

    • 7.1 Tohoku Inactivated Vaccine Landscape Analysis by Major Types

    • 7.2 Tohoku Inactivated Vaccine Landscape Analysis by Major End-Users

    8 Kanto Inactivated Vaccine Landscape Analysis

    • 8.1 Kanto Inactivated Vaccine Landscape Analysis by Major Types

    • 8.2 Kanto Inactivated Vaccine Landscape Analysis by Major End-Users

    9 Chubu Inactivated Vaccine Landscape Analysis

    • 9.1 Chubu Inactivated Vaccine Landscape Analysis by Major Types

    • 9.2 Chubu Inactivated Vaccine Landscape Analysis by Major End-Users

    10 Kinki Inactivated Vaccine Landscape Analysis

    • 10.1 Kinki Inactivated Vaccine Landscape Analysis by Major Types

    • 10.2 Kinki Inactivated Vaccine Landscape Analysis by Major End-Users

    11 Chugoku Inactivated Vaccine Landscape Analysis

    • 11.1 Chugoku Inactivated Vaccine Landscape Analysis by Major Types

    • 11.2 Chugoku Inactivated Vaccine Landscape Analysis by Major End-Users

    12 Shikoku Inactivated Vaccine Landscape Analysis

    • 12.1 Shikoku Inactivated Vaccine Landscape Analysis by Major Types

    • 12.2 Shikoku Inactivated Vaccine Landscape Analysis by Major End-Users

    13 Kyushu Inactivated Vaccine Landscape Analysis

    • 13.1 Kyushu Inactivated Vaccine Landscape Analysis by Major Types

    • 13.2 Kyushu Inactivated Vaccine Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Pfizer (U.S.)

      • 14.1.1 Pfizer (U.S.) Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 GlaxoSmithKline (U.K.)

      • 14.2.1 GlaxoSmithKline (U.K.) Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Emergent BioSolutions (U.S.)

      • 14.3.1 Emergent BioSolutions (U.S.) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Serum Institute of India Pvt (India)

      • 14.4.1 Serum Institute of India Pvt (India) Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Johnson & Johnson (U.S.)

      • 14.5.1 Johnson & Johnson (U.S.) Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 MedImmune (U.S.)

      • 14.6.1 MedImmune (U.S.) Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Merck & Co (U.S.)

      • 14.7.1 Merck & Co (U.S.) Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Astellas Pharma (Japan)

      • 14.8.1 Astellas Pharma (Japan) Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Pfizer (US)

      • 14.9.1 Pfizer (US) Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Sanofi Pasteur (France)

      • 14.10.1 Sanofi Pasteur (France) Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 134 Figures and 183 Tables)

    • Figure Japan Inactivated Vaccine Market Size and Growth Rate of Pediatrics from 2014 to 2026

    • Figure Japan Inactivated Vaccine Market Size and Growth Rate of Adults from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Inactivated Vaccine Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Japan Inactivated Vaccine Market Size and Growth Rate of Medical Center from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Inactivated Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Inactivated Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Inactivated Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Inactivated Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Inactivated Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Pediatrics

    • Figure Market Size and Growth Rate of Adults

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Inactivated Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Inactivated Vaccine by Different End-Users from 2014 to 2026

    • Figure Japan Inactivated Vaccine Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Japan Inactivated Vaccine Market Size and Growth Rate of Medical Center from 2014 to 2026

    • Table Japan Inactivated Vaccine Production by Regions

    • Table Japan Inactivated Vaccine Production Share by Regions

    • Figure Japan Inactivated Vaccine Production Share by Regions in 2014

    • Figure Japan Inactivated Vaccine Production Share by Regions in 2018

    • Figure Japan Inactivated Vaccine Production Share by Regions in 2026

    • Table Japan Inactivated Vaccine Consumption by Regions

    • Table Japan Inactivated Vaccine Consumption Share by Regions

    • Figure Japan Inactivated Vaccine Consumption Share by Regions in 2014

    • Figure Japan Inactivated Vaccine Consumption Share by Regions in 2018

    • Figure Japan Inactivated Vaccine Consumption Share by Regions in 2026

    • Table Hokkaido Inactivated Vaccine Consumption by Types from 2014 to 2026

    • Table Hokkaido Inactivated Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Inactivated Vaccine Consumption Share by Types in 2014

    • Figure Hokkaido Inactivated Vaccine Consumption Share by Types in 2018

    • Figure Hokkaido Inactivated Vaccine Consumption Share by Types in 2026

    • Table Hokkaido Inactivated Vaccine Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Inactivated Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Inactivated Vaccine Consumption Share by End-Users in 2014

    • Figure Hokkaido Inactivated Vaccine Consumption Share by End-Users in 2018

    • Figure Hokkaido Inactivated Vaccine Consumption Share by End-Users in 2026

    • Table Tohoku Inactivated Vaccine Consumption by Types from 2014 to 2026

    • Table Tohoku Inactivated Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Inactivated Vaccine Consumption Share by Types in 2014

    • Figure Tohoku Inactivated Vaccine Consumption Share by Types in 2018

    • Figure Tohoku Inactivated Vaccine Consumption Share by Types in 2026

    • Table Tohoku Inactivated Vaccine Consumption by End-Users from 2014 to 2026

    • Table Tohoku Inactivated Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Inactivated Vaccine Consumption Share by End-Users in 2014

    • Figure Tohoku Inactivated Vaccine Consumption Share by End-Users in 2018

    • Figure Tohoku Inactivated Vaccine Consumption Share by End-Users in 2026

    • Table Kanto Inactivated Vaccine Consumption by Types from 2014 to 2026

    • Table Kanto Inactivated Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kanto Inactivated Vaccine Consumption Share by Types in 2014

    • Figure Kanto Inactivated Vaccine Consumption Share by Types in 2018

    • Figure Kanto Inactivated Vaccine Consumption Share by Types in 2026

    • Table Kanto Inactivated Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kanto Inactivated Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Inactivated Vaccine Consumption Share by End-Users in 2014

    • Figure Kanto Inactivated Vaccine Consumption Share by End-Users in 2018

    • Figure Kanto Inactivated Vaccine Consumption Share by End-Users in 2026

    • Table Chubu Inactivated Vaccine Consumption by Types from 2014 to 2026

    • Table Chubu Inactivated Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Chubu Inactivated Vaccine Consumption Share by Types in 2014

    • Figure Chubu Inactivated Vaccine Consumption Share by Types in 2018

    • Figure Chubu Inactivated Vaccine Consumption Share by Types in 2026

    • Table Chubu Inactivated Vaccine Consumption by End-Users from 2014 to 2026

    • Table Chubu Inactivated Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Inactivated Vaccine Consumption Share by End-Users in 2014

    • Figure Chubu Inactivated Vaccine Consumption Share by End-Users in 2018

    • Figure Chubu Inactivated Vaccine Consumption Share by End-Users in 2026

    • Table Kinki Inactivated Vaccine Consumption by Types from 2014 to 2026

    • Table Kinki Inactivated Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kinki Inactivated Vaccine Consumption Share by Types in 2014

    • Figure Kinki Inactivated Vaccine Consumption Share by Types in 2018

    • Figure Kinki Inactivated Vaccine Consumption Share by Types in 2026

    • Table Kinki Inactivated Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kinki Inactivated Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Inactivated Vaccine Consumption Share by End-Users in 2014

    • Figure Kinki Inactivated Vaccine Consumption Share by End-Users in 2018

    • Figure Kinki Inactivated Vaccine Consumption Share by End-Users in 2026

    • Table Chugoku Inactivated Vaccine Consumption by Types from 2014 to 2026

    • Table Chugoku Inactivated Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Inactivated Vaccine Consumption Share by Types in 2014

    • Figure Chugoku Inactivated Vaccine Consumption Share by Types in 2018

    • Figure Chugoku Inactivated Vaccine Consumption Share by Types in 2026

    • Table Chugoku Inactivated Vaccine Consumption by End-Users from 2014 to 2026

    • Table Chugoku Inactivated Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Inactivated Vaccine Consumption Share by End-Users in 2014

    • Figure Chugoku Inactivated Vaccine Consumption Share by End-Users in 2018

    • Figure Chugoku Inactivated Vaccine Consumption Share by End-Users in 2026

    • Table Shikoku Inactivated Vaccine Consumption by Types from 2014 to 2026

    • Table Shikoku Inactivated Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Inactivated Vaccine Consumption Share by Types in 2014

    • Figure Shikoku Inactivated Vaccine Consumption Share by Types in 2018

    • Figure Shikoku Inactivated Vaccine Consumption Share by Types in 2026

    • Table Shikoku Inactivated Vaccine Consumption by End-Users from 2014 to 2026

    • Table Shikoku Inactivated Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Inactivated Vaccine Consumption Share by End-Users in 2014

    • Figure Shikoku Inactivated Vaccine Consumption Share by End-Users in 2018

    • Figure Shikoku Inactivated Vaccine Consumption Share by End-Users in 2026

    • Table Kyushu Inactivated Vaccine Consumption by Types from 2014 to 2026

    • Table Kyushu Inactivated Vaccine Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Inactivated Vaccine Consumption Share by Types in 2014

    • Figure Kyushu Inactivated Vaccine Consumption Share by Types in 2018

    • Figure Kyushu Inactivated Vaccine Consumption Share by Types in 2026

    • Table Kyushu Inactivated Vaccine Consumption by End-Users from 2014 to 2026

    • Table Kyushu Inactivated Vaccine Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Inactivated Vaccine Consumption Share by End-Users in 2014

    • Figure Kyushu Inactivated Vaccine Consumption Share by End-Users in 2018

    • Figure Kyushu Inactivated Vaccine Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Pfizer (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer (U.S.)

    • Figure Sales and Growth Rate Analysis of Pfizer (U.S.)

    • Figure Revenue and Market Share Analysis of Pfizer (U.S.)

    • Table Product and Service Introduction of Pfizer (U.S.)

    • Table Company Profile and Development Status of GlaxoSmithKline (U.K.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline (U.K.)

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline (U.K.)

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline (U.K.)

    • Table Product and Service Introduction of GlaxoSmithKline (U.K.)

    • Table Company Profile and Development Status of Emergent BioSolutions (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions (U.S.)

    • Figure Sales and Growth Rate Analysis of Emergent BioSolutions (U.S.)

    • Figure Revenue and Market Share Analysis of Emergent BioSolutions (U.S.)

    • Table Product and Service Introduction of Emergent BioSolutions (U.S.)

    • Table Company Profile and Development Status of Serum Institute of India Pvt (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India Pvt (India)

    • Figure Sales and Growth Rate Analysis of Serum Institute of India Pvt (India)

    • Figure Revenue and Market Share Analysis of Serum Institute of India Pvt (India)

    • Table Product and Service Introduction of Serum Institute of India Pvt (India)

    • Table Company Profile and Development Status of Johnson & Johnson (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson (U.S.)

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson (U.S.)

    • Figure Revenue and Market Share Analysis of Johnson & Johnson (U.S.)

    • Table Product and Service Introduction of Johnson & Johnson (U.S.)

    • Table Company Profile and Development Status of MedImmune (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune (U.S.)

    • Figure Sales and Growth Rate Analysis of MedImmune (U.S.)

    • Figure Revenue and Market Share Analysis of MedImmune (U.S.)

    • Table Product and Service Introduction of MedImmune (U.S.)

    • Table Company Profile and Development Status of Merck & Co (U.S.)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co (U.S.)

    • Figure Sales and Growth Rate Analysis of Merck & Co (U.S.)

    • Figure Revenue and Market Share Analysis of Merck & Co (U.S.)

    • Table Product and Service Introduction of Merck & Co (U.S.)

    • Table Company Profile and Development Status of Astellas Pharma (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma (Japan)

    • Figure Sales and Growth Rate Analysis of Astellas Pharma (Japan)

    • Figure Revenue and Market Share Analysis of Astellas Pharma (Japan)

    • Table Product and Service Introduction of Astellas Pharma (Japan)

    • Table Company Profile and Development Status of Pfizer (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer (US)

    • Figure Sales and Growth Rate Analysis of Pfizer (US)

    • Figure Revenue and Market Share Analysis of Pfizer (US)

    • Table Product and Service Introduction of Pfizer (US)

    • Table Company Profile and Development Status of Sanofi Pasteur (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur (France)

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur (France)

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur (France)

    • Table Product and Service Introduction of Sanofi Pasteur (France)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.